Efficacy of radiofrequency ablation therapy compared to surgical resection in 164 patients in Japan with single hepatocellular carcinoma smaller than 3 cm, along with report of complications

Hepato-Gastroenterology

Volumn 55, Issue 88, 2008, Pages 2171-2174

  Hiraoka, Atsushi ^a   Horiike, Norio ^a   Yamashita, Yoshmiasa ^a   Koizumi, Yohei ^a   Doi, Kazuhiro ^a   Yamamoto, Yasinori ^a   Hasebe, Aki ^a   Ichikawa, Soichi ^a   Yano, Makoto ^a   Miyamoto, Yasunao ^a   Ninomiya, Tomoyuki ^a   Otomi, Yoichi ^a   Kokame, Masahiro ^a   Iwamura, Takuaki ^a   Ishimaru, Yoshihiro ^a   Sogabe, Ichiro ^a   Kashihara, Kenichi ^a   Nishiura, Saburo ^a   Ootani, Hiromi ^a   Takamura, Kazuhito ^a   Kawasaki, Hideki ^a   more..

^a EHIME PREFECTURAL CENTRAL HOSPITAL   (Japan)

Author keywords

Hepatocellular carcinoma; Radio frequency ablation therapy; Surgical resection; Survival rate

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; DISEASE CLASSIFICATION; DISEASE FREE SURVIVAL; FEMALE; HUMAN; INTERMETHOD COMPARISON; JAPAN; LIVER ABSCESS; LIVER CELL CARCINOMA; LIVER FAILURE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; PRIORITY JOURNAL; RADIOFREQUENCY ABLATION; RETROSPECTIVE STUDY; SURVIVAL RATE; TUMOR VOLUME;

AGED; CARCINOMA, HEPATOCELLULAR; CATHETER ABLATION; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; RETROSPECTIVE STUDIES;

EID: 60849117545     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Shiina S, Teratani T, Obi S, et al. A randomized controlled trial of radiofrequency ablation with ethanol injection for small hepatocellular carcinoma. Gastroenterology 2005; 129:122-130.
2. Lencioni R, Cioni D, Crocetti L, et al. Early stage hepatocellular carcinoma in patients with cirrhosis long term results of percutaneous image-guided radiofrequency ablation. Radiology 2005; 234:961-967.
3. Motorsi M, Santambrogio R, Bianchi P, et al. Survival and reccurences after hepatic resection or radiofrequency for hepatocellular carcinoma in cirrhotic patients: a multivariate analysis. J Gastrointest Surg 2005; 9:62-67.
4. Vivarelli M, Guglielmi A, Ruzzenente A, et al. Surgical resection versus percutaneous radiofrequency ablation in the treatment of hepatocellular carcinoma on cirrhotic liver. Ann Surg 2004; 240:102-107.
5. Liver Cancer Study Group of Japan. The general rules for the clinical and pathological study of primary liver cancer 4th ed. Kanehara, Tokyo, 2000:p19 (in Japanese).
6. Kudo M, Chung H, Haji S, Osaki Y, Oka H, Seki T, Kasugai H, Sasaki Y, Matsunaga T. Validation of a new prognostic staging system for hepatocellular carcinoma: the JIS score compared with CLIP score. Hepatology 2004; 40:1396-1405.
7. Minami Y, Kudo M, Kawasaki T, et al. Percutaneous ultrasound-guided radiofrequency ablation with artificial pleural effusion for hepatocellular carcinoma in the hepatic dome. J Gastroenterol 2003; 38:1066-1070.
8. Uehara T, Hirooka M, Ishida K et al. Percutaneous ultrasound-guided radiofrequency ablation of hepatocellular carcinoma with artificially induced pleural effusion and ascites. J Gastroenterol 2007; 42:306-11.
9. Hirooka M, Iuchi H, Kumagi T, et al. Virtual Sonographic Radiofrequency Ablation of Hepatocellular Carcinoma Visualized on CT but Not on Conventional Sonography. AJR Am J Roentgenol 2006; 186:S255-260.
10. Honda H, Onitsuka H, Yasumori K, Hayashi T, Ochiai K, Gibo M, Adachi F, Matsumata T, Masuda K. Intrahepatic peripheral holangiocarcinoma: two-phased dynamic incremental CT and pathologic correlation. J Comput Assist Tomogr 1993; 17:397-402.
11. Lecomis JM, Baron RL, Oliver JH 3rd, Nalesnik MA, Federle MP. Cholangiocarcinoma: delayed CT contrast enhancement patterns. Radiology 1997; 203:98-104.
12. Bruix J, Sherman M. Management of hepatocellular carcinoma. Hepatology 2005; 42:1208-1236.
13. Taketa K, Endo Y, Sekiya C, et al. A collaborative study for the evaluation of lectin-reactive alpha-fetoproteins in early detection of hepatocellular carcinoma. Cancer Res. 1993; 53:5419-5423.
14. Aoyagi Y, Suzuki Y, Igarashi K, et al. The usefulness of simultaneous determinations of glucosaminylation and fucosylation indices of alpha-fetoprotein in the differential diagnosis of neoplastic diseases of the liver. Cancer 1991; 67:2390-2394.
15. Liebman HA, Furie BC, Tong MJ, et al. Des-gamma-carboxy (abnormal) prothrombin as a serum marker of primary hepatocellular carcinoma. N Engl J Med 1984; 310:1427-1431.
16. Nakao A, Taniguchi K, Inoue S, et al. Clinical application of a new monoclonal antibody (19B7) against PIVKA-II in the diagnosis of hepatocellular carcinoma and pancreatobiliary malignancies. Am J Gastroenterol 1997; 92:1031-1034.
17. Kuromatsu R, Tanaka M, Shimauchi Y, et al. Usefulness of ED036 kit for measuring serum PIVKA-II levels in small hepatocellular carcinoma. J Gastroenterol 1997;32:507-512.
18. Makuuchi M, Kokudo N. Clinical practice guidelines for hepatocellular carcinoma: the first evidence based guidelines from Japan. World J Gastroenterol 2006; 12:828-829.
19. Lam CM, Ng KK, Poon RT. et al. Impact of radiofrequency ablation on the management of patients with hepatocellular carcinoma in a single specialized centre. Br J Surg 2004; 91:334-338.
20. Giorgio A, Tarantino L. de Stefano G, et al. Percutaneous sonography guided saline-enhanced radiofrequency ablation of hepatocellular carcinoma. Am J Roentgenol 2003; 181:479-484.
21. Takayasu K, Arii S, Ikai I et al. Prospective cohort study of transarterial chemoembolization for unresectable hepatocellular carcinoma in 8510 patients. Gastroenterology 2006; 131:461-469.
22. Hiraoka A, Kumagi T, Hirooka M, et al. Prognosis following transcatheter arterial embolization for 121 patients with unresectable hepatocellular carcinoma with or without a history of treatment. World J Gastroenterol 2006; 12:2075-2079.
23. Mazzafero V, Regalia E, Doci R, Andreola S, at al. Liver transplantation for the treatment of small hepatocellula carcinomas in patients with cirrhosis. N Engl J Med 1996; 334:693-699.
24. Tateishi R, Shiina S, Teratani T, et al. Percutaneous radio-frequency ablation for hepatocellular carcinoma. An analysis of 1000 cases. Cancer 2005; 103:1201-1209.